DrugBiological

Rituximab clinical trials

Also written Rituxan, MabThera, IDEC-C2B8 and IDEC-102.

Includes 3 studies of 131I-rituximab.

studies test it: 1,389
open now: 177
in phase 3: 247
first study started: 1993

Keep track of what changes. Save the Rituximab studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

How studies write it

Studies that test it under each name

Biosimilars in development

GP2013: 5
BI 695500: 4
ABP 798: 3
CT-P10: 3
PF-05280586: 3
JHL1101: 3
SAIT101: 2
IBI301: 2

Studies by the year they started

1,377 studies that test it; most in 2006 (86); 1 more planned to start later

Studies that test Rituximab, by start year
Year	Studies
1993	1
1995	2
1997	6
1998	16
1999	18
2000	19
2001	22
2002	33
2003	53
2004	75
2005	74
2006	86
2007	70
2008	68
2009	71
2010	59
2011	62
2012	63
2013	47
2014	43
2015	52
2016	46
2017	28
2018	39
2019	48
2020	46
2021	36
2022	31
2023	49
2024	36
2025	41
2026	37

By phase

A phase 1/2 study counts in both.

Early Phase 1: 15
Phase 1: 314
Phase 2: 876
Phase 3: 247
Phase 4: 65
No phase: 48

What it is tested for

Each study’s main condition, where its own words name it.

Lymphoma: 169
Lymphoma, Non-Hodgkin: 164
Lymphoma, Large B-Cell, Diffuse: 138
Leukemia, Lymphocytic, Chronic, B-Cell: 97
Lymphoma, Mantle-Cell: 81
Lymphoma, Follicular: 70
Arthritis, Rheumatoid: 61
Lymphoma, B-Cell: 35
Waldenstrom Macroglobulinemia: 34
Burkitt Lymphoma: 33
Purpura, Thrombocytopenic, Idiopathic: 23
Nephrotic Syndrome: 18

Who runs them

Industry 262 · Other 1,127

M.D. Anderson Cancer Center (81) · Hoffmann-La Roche (69) · National Cancer Institute (NCI) (59) · Memorial Sloan Kettering Cancer Center (26) · Mayo Clinic (24) · Genentech, Inc. (24) · Assistance Publique - Hôpitaux de Paris (22) · Alliance for Clinical Trials in Oncology (19)

Often tested with

Tested in the same studies.

Cyclophosphamide (163) · Lenalidomide (99) · Fludarabine (91) · Bendamustine (83) · Vincristine (65) · Prednisone (65) · Bortezomib (63) · Doxorubicin (58)

Studies

Open first, then newest update. How each study uses Rituximab is read from its arms, and is right about nine times in ten.

Testing it · 1,389

See all 1,389 studies that test Rituximab →

Given in every arm · 453 — Rituximab is usual care beside what is tested

Showing 20 of 453.

As the comparator · 97 — what is tested is compared with Rituximab

Showing 20 of 97.

Codes

What other systems call Rituximab · ClinicalTrials.gg INT006567

MeSH (NLM) D000069283RituximabConfirmed ClinicalTrials.gov, NLM, Wikidata
UNII (FDA) 4F4X42SYQ6RITUXIMABConfirmed FDA, NLM, Wikidata
RxNorm 121191Confirmed FDA, Wikidata
Wikidata Q412323rituximabConfirmed FDA, NLM, Wikidata
NCI Thesaurus C1702RituximabOne source FDA
DrugBank DB00073One source Wikidata

System	Code	Name there	Checked by
MeSH (NLM)	D000069283	Rituximab	Confirmed ClinicalTrials.gov, NLM, Wikidata
UNII (FDA)	4F4X42SYQ6	RITUXIMAB	Confirmed FDA, NLM, Wikidata
RxNorm	121191	—	Confirmed FDA, Wikidata
Wikidata	Q412323	rituximab	Confirmed FDA, NLM, Wikidata
NCI Thesaurus	C1702	Rituximab	One source FDA
DrugBank	DB00073	—	One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.